NatWest Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-653
| Closed | -$207K | – | 63 |
|
|
2020
Q1 | $207K | Buy |
+653
| New | +$207K | 0.06% | 80 |
|
|
2018
Q4 | – | Sell |
-692
| Closed | -$244K | – | 77 |
|
|
2018
Q3 | $244K | Sell |
692
-160
| -19% | -$56.4K | 0.04% | 72 |
|
|
2018
Q2 | $247K | Hold |
852
| – | – | 0.05% | 74 |
|
|
2018
Q1 | $233K | Sell |
852
-80
| -9% | -$21.9K | 0.05% | 78 |
|
|
2017
Q4 | $297K | Sell |
932
-95
| -9% | -$30.3K | 0.07% | 69 |
|
|
2017
Q3 | $322K | Sell |
1,027
-10
| -1% | -$3.14K | 0.08% | 85 |
|
|
2017
Q2 | $282K | Sell |
1,037
-100
| -9% | -$27.2K | 0.07% | 88 |
|
|
2017
Q1 | $311K | Sell |
1,137
-1,710
| -60% | -$468K | 0.07% | 91 |
|
|
2016
Q4 | $807K | Sell |
2,847
-740
| -21% | -$210K | 0.21% | 60 |
|
|
2016
Q3 | $1.12M | Sell |
3,587
-464
| -11% | -$145K | 0.26% | 59 |
|
|
2016
Q2 | $980K | Sell |
4,051
-8,524
| -68% | -$2.06M | 0.25% | 62 |
|
|
2016
Q1 | $3.27M | Sell |
12,575
-3,054
| -20% | -$795K | 0.73% | 34 |
|
|
2015
Q4 | $4.79M | Sell |
15,629
-8,741
| -36% | -$2.68M | 0.96% | 34 |
|
|
2015
Q3 | $7.11M | Buy |
24,370
+1,382
| +6% | +$403K | 0.16% | 84 |
|
|
2015
Q2 | $9.29M | Buy |
22,988
+2,827
| +14% | +$1.14M | 0.12% | 68 |
|
|
2015
Q1 | $8.51M | Buy |
20,161
+3,250
| +19% | +$1.37M | 0.11% | 79 |
|
|
2014
Q4 | $5.74K | Buy |
16,911
+5,598
| +49% | +$1.9K | 0.05% | 107 |
|
|
2014
Q3 | $3.74K | Buy |
11,313
+7
| +0.1% | +$2 | 0.03% | 144 |
|
|
2014
Q2 | $3.56M | Buy |
11,306
+2,873
| +34% | +$906K | 0.15% | 147 |
|
|
2014
Q1 | $2.58M | Sell |
8,433
-18,752
| -69% | -$5.74M | 0.11% | 154 |
|
|
2013
Q4 | $7.6M | Buy |
27,185
+5,753
| +27% | +$1.61M | 0.19% | 119 |
|
|
2013
Q3 | $5.16M | Sell |
21,432
-35,929
| -63% | -$8.65M | 0.15% | 144 |
|
|
2013
Q2 | $12.3M | Buy |
+57,361
| New | +$12.3M | 0.18% | 99 |
|